ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 26074 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 26074; 2) Community: the network communities that were significantly associated with the response to NSC 26074; 3) Molecule: the relationships between components within communities and NSC 26074; 4) MDR: the compounds that were significantly associated with the NSC 26074.

NSC Compound Enrichment Correlation
NSC 720616 Null 0.0459335986102865 -0.11817892
NSC 730035 6-amino-5-(4-fluorobenzyl)-7-(1-methyl-1H-benzo[d]imidazol-2 -yl)-5H-pyrrolo[2,3-b]pyrazine-2,3-dicarbonitrile 0.0459335986102865 0.037751415
NSC 302991 Camptothecin Derivative 0.0462077035966078 0.09361684
NSC 364830 Camptothecin Derivative 0.0462077035966078 -0.020136917
NSC 610457 Camptothecin Derivative 0.0462077035966078 0.032542249
NSC 655266 Null 0.0462077035966078 -0.05218503
NSC 698379 1,3-Butadiene-1,4-diamine, 1-(1H-benzotriazol-1-yl)-3,4-dichloro- N,N'-bis[4-ethoxyphenyl]-2-nitro- 0.0462077035966078 0.21520497
NSC 726144 Waol A FD-211 0.0462077035966078 0.15298191
NSC 751393 2-(4,5-dibenzoyl-1,3-dithiol-2-ylidene)-1-ethyl-6-(phenylimino)-3-thioxo-2,3-dihydro-1H-thieno[2,3-b][1,4]thiazin-7(6H)-one 0.0462077035966078 0.21205662
NSC 117281 ANTINEOPLASTIC-117281 0.0462077035966081 0.19529997
Total:90  Current:82    [First] [Prev] [Next] [Last]